CapsoVision Inc の最大収益セグメントは Capsules and Capsule Reading Devices で、最新の利益発表における収益は 12,638,000 です。地域別に見ると、United States が CapsoVision Inc の主要市場であり、収益は 10,657,000 です。
CapsoVision Incは収益を上げていますか?
いいえ、最新の財務諸表によると、CapsoVision Incの純損失は$0です。
CapsoVision Incに負債はありますか?
いいえ、CapsoVision Incの負債は0です。
CapsoVision Incの発行済株式数は何株ですか?
CapsoVision Incの総発行済株式数は0株です。
主要データ
前終値
$6.57
始値
$6.53
当日レンジ
$6.29 - $6.69
52週レンジ
$3.43 - $15.37
取引高
101.8K
平均取引高
338.6K
配当利回り
--
1株当たり利益(TTM)
-0.54
時価総額
$322.9M
CVとは何ですか?
CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California and currently employs 28 full-time employees. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.